Biomimetic Therapeutics Quick Ratio (BMTI) starting from the third quarter 2012 to third quarter 2011, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Biomimetic Therapeutics, Inc.  (BMTI)

Biomimetic Therapeutics's Quick Ratio

BMTI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2012, Quick Ratio deteriorated to 10.39 below Biomimetic Therapeutics's average Quick Ratio.

Within Medical Equipment & Supplies industry Biomimetic Therapeutics, Inc. booked the highest Quick Ratio than Biomimetic Therapeutics in the third quarter 2012. While Quick Ratio total ranking in the third quarter 2012 has deteriorated compared to the prior quarter from 145 to 157.

Explain Quick Ratio?
How much Cash & cash equivalents BMTI´s has?
What are BMTI´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMTI Quick Ratio (Sep 30 2012)
Q3		 (Jun 30 2012)
Q2		 (Mar 31 2012)
Q1		 (Dec 31 2011)
Q4		 (Sep 30 2011)
Q3
Y / Y Current Liabilities Change -3.93 % 0.54 % -24.19 % - -
Y / Y Cash & cash equivalent Change -33.71 % -28.68 % -29.56 % - -
Quick Ratio MRQ 10.39 11.11 13.54 9.43 15.05
BMTI's Total Ranking # 157 # 145 # 188 # 0 #
Seq. Current Liabilities Change -3.52 % 9.72 % -38.21 % 46.86 % 0.98 %
Seq. Cash & cash equivalent Change -9.85 % -9.92 % -11.3 % -7.97 % -3.01 %



Quick Ratio third quarter 2012 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 1
Healthcare Sector # 42
Overall Market # 157


Quick Ratio Statistics
High Average Low
13.54 11.12 9.43
(Mar 31 2012)   (Dec 31 2011)




Financial Statements
Biomimetic Therapeutics's Current Liabilities $ 4 Millions Visit BMTI's Balance sheet
Biomimetic Therapeutics's Cash & cash equivalent $ 44 Millions Visit BMTI's Balance sheet
Source of BMTI's Sales Visit BMTI's Sales by Geography


Cumulative Biomimetic Therapeutics's Quick Ratio

BMTI's Quick Ratio for the trailling 12 Months

BMTI Quick Ratio

 (Sep 30 2012)
12 Months		 (Jun 30 2012)
12 Months		 (Mar 31 2012)
12 Months		 (Dec 31 2011)
12 Months		 (Sep 30 2011)
12 Months
Y / Y Current Liabilities TTM Growth 35.93 % 99.87 % 264.77 % - -
Y / Y Cash & cash equivalent TTM Growth -1.72 % 58.55 % 225.13 % - -
Quick Ratio TTM 10.89 11.95 12.99 13.29 15.06
Total Ranking TTM # 727 # 0 # 0 # 0 #
Seq. Current Liabilities TTM Growth -0.9 % 0.12 % -6.22 % 46.07 % 45.72 %
Seq. Cash & cash equivalent TTM Growth -9.71 % -7.85 % -8.33 % 28.85 % 45.66 %

Quick ratio ranking by company, industry and sector >> Back to BMTI Financial Strength Comparisons >> Go to Compare BMTI Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in BMTI's Current Liabilities to $4.26 millions, cumulative Quick Ratio to 10.89 below the BMTI average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 15 other companies have achieved higher Quick Ratio than Biomimetic Therapeutics. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2012 from 0 to 727.

Explain Quick Ratio?
How much Cash & cash equivalents BMTI´s has?
What are BMTI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 16
Healthcare Sector # 65
Within the Market # 727


trailing twelve months Quick Ratio Statistics
High Average Low
10.89 10.89 10.89
(Sep 30 2012)  




Companies with similar Quick Ratio in the quarter ending Sep 30 2012, within Medical Equipment & Supplies Industry Quick RatioSep 30 2012 MRQ Cash & cash equivalentSep 30 2012 MRQ Current Liabilities
Wright Medical Group N v   22.14 $ 317.622  Millions$ 14.344  Millions
Biomimetic Therapeutics, Inc.  10.39 $ 44.266  Millions$ 4.262  Millions
Renovacare Inc   9.90 $ 0.578  Millions$ 0.058  Millions
Perspective Therapeutics Inc   8.69 $ 5.029  Millions$ 0.578  Millions
Zimmer Biomet Holdings Inc   8.69 $ 1,602.700  Millions$ 184.400  Millions
Microbot Medical Inc   7.95 $ 21.744  Millions$ 2.736  Millions
Nuwellis Inc   7.68 $ 17.446  Millions$ 2.271  Millions
Achari Ventures Holdings Corp I  7.63 $ 103.722  Millions$ 13.586  Millions
Icu Medical Inc  7.07 $ 204.292  Millions$ 28.910  Millions
Genmark Diagnostics Inc   6.92 $ 53.371  Millions$ 7.716  Millions
Regentis Biomaterials Ltd   5.87 $ 0.148  Millions$ 0.025  Millions
Globus Medical Inc   5.73 $ 195.156  Millions$ 34.074  Millions
Strata Skin Sciences Inc  5.64 $ 13.276  Millions$ 2.355  Millions
Orasure Technologies Inc  5.26 $ 89.416  Millions$ 16.999  Millions
Alpha Pro Tech Ltd   5.17 $ 5.891  Millions$ 1.140  Millions
Abiomed Inc   4.52 $ 88.981  Millions$ 19.703  Millions
Atrion Corporation  4.47 $ 38.695  Millions$ 8.665  Millions
Cutera Inc   4.43 $ 80.129  Millions$ 18.082  Millions
Neurometrix Inc   4.32 $ 10.926  Millions$ 2.528  Millions
Surmodics Inc   4.30 $ 29.657  Millions$ 6.899  Millions
Retractable Technologies Inc  4.19 $ 25.009  Millions$ 5.962  Millions
Antares Pharma Inc   4.09 $ 30.212  Millions$ 7.381  Millions
Resmed Inc   3.52 $ 890.629  Millions$ 253.031  Millions
Koru Medical Systems Inc   3.48 $ 1.940  Millions$ 0.558  Millions
Cas Medical Systems Inc  3.43 $ 11.143  Millions$ 3.245  Millions
Anika Therapeutics Inc   3.28 $ 39.856  Millions$ 12.155  Millions
Ufp Technologies Inc   3.16 $ 31.155  Millions$ 9.857  Millions
Intuitive Surgical Inc   3.13 $ 1,141.400  Millions$ 364.900  Millions
Star Equity Holdings Inc   3.09 $ 27.413  Millions$ 8.879  Millions
Asensus Surgical Inc   3.06 $ 2.631  Millions$ 0.860  Millions

Date modified: 2026-09-08T15:07:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.